Tag Archives: natalizumab

Gilenya fingolimod Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Gilenya (fingolimod) – Drug Safety Communication: Investigating Rare Brain Infection AUDIENCE: Neurology, Pharmacy ISSUE: FDA is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis … Continue reading

Share
Posted in FDA 2013, FDA Notice, multiple sclerosis (MS), Neurology, Pharmacy | Tagged , , , , , , , , , , , , , | Comments Off

Tysabri (natalizumab) Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseTysabri (natalizumab): Drug Safety Communication – New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML) AUDIENCE: Neurology, Gastroenterology ISSUE: FDA notified healthcare profesisonals that testing positive for anti-JC virus (JCV) antibodies … Continue reading

Share
Posted in FDA 2012, FDA Notice, Gastroenterology, Neurology | Tagged , , , , , , , , | Comments Off